BioSpace News Archive

Laser vision correction is an alternative to eyeglasses and contact lenses, which can help to see correctly, naturally.

DUBAI, United Arab Emirates, According to the exclusive report of Future Market Insights, the global interventional radiology market is expected to grow at a CAGR of 5.4% during the forecast period by going up from US$ 24.9 Bn in 2021 to US$ 44.5 Bn market in 2032.

DUBAI, United Arab Emirates, According to Future Market Insights, the glaucoma treatment market is forecasted to reach a net worth of US$ 7.6 Bn in 2032 from US$ 5.5 Bn in 2021 by registering a moderate CAGR of 3%.

Albany NY, United States: Shigella infection, also termed as shigellosis, is an intestinal disease caused by the bacteria family of shigella. Shigella infection is easier to transmit in the body through stool with bacteria.

AGC Inc. (hereinafter “AGC”), a Tokyo -based world-leading manufacturer of glass, chemicals, high-tech materials, has decided to expand the facilities of AGC Pharma Chemicals Europe S.L.U. (hereinafter “APCE”), an AGC subsidiary in Spain engaged in the synthetic pharmaceutical (*1) CDMO (*2) business.

Exact Sciences Corp., a leader in advanced cancer diagnostics, announced that the company plans to release its first quarter 2022 financial results after the close of the U.S. financial markets on April 26, 2022.

Renalytix Plc (NASDAQ: RNLX) (LSE: RENX) announces that under the Company’s Employee Share Purchase Plan (the “ESPP”), 22,814 new ordinary shares of £0.0025 each in the capital of the Company (the “Ordinary Shares”) have been issued to settle the purchase of 11,407 American Depositary Shares, each representing two Ordinary Shares, by employees who participated in the ESPP.

Amphastar Pharmaceuticals, Inc., announced that the U.S. Food and Drug Administration has approved the Company’s Abbreviated New Drug Application for Ganirelix Acetate Injection, 250mg/0.5mL in a prefilled syringe.

DUBAI, United Arab Emirates, According to an analysis by Future Market Insights, the flexible endoscopes market is expected to be valued at US$ 12 bn in 2032, with a 7% CAGR during the forecast period.

DUBAI, United Arab Emirates, With an estimated CAGR of 12.8% during the projected period, the antibody therapy market share is expected to reach US$ 700 Billion by 2032, from US$ 186 Bn in a report published by FMI.